Filing Details
- Accession Number:
- 0001209191-21-058512
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-01 17:09:48
- Reporting Period:
- 2021-09-01
- Accepted Time:
- 2021-10-01 17:09:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-01 | 85 | $2.88 | 175,655 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-02 | 85 | $2.88 | 175,740 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-03 | 85 | $2.85 | 175,825 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-07 | 85 | $2.79 | 175,910 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-08 | 85 | $2.89 | 175,995 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-09 | 85 | $2.77 | 176,080 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-10 | 85 | $2.78 | 176,165 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-13 | 85 | $2.96 | 176,250 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-14 | 85 | $3.02 | 176,335 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-15 | 85 | $2.86 | 176,420 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-16 | 85 | $2.91 | 176,505 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-17 | 85 | $2.85 | 176,590 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-20 | 85 | $2.82 | 176,675 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-21 | 85 | $2.81 | 176,760 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-22 | 85 | $2.76 | 176,845 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-23 | 85 | $2.75 | 176,930 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-24 | 85 | $2.74 | 177,015 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-27 | 85 | $2.79 | 177,100 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-28 | 85 | $2.76 | 177,185 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-29 | 85 | $2.82 | 177,270 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-30 | 85 | $2.72 | 177,355 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
